For patients ≥ 11 years of age, the initial dose by subcutaneous or intravenous administration is 0.45 µg/ kg body weight, as a single injection once weekly.
pa Yli 11- vuotiaiden potilaiden aloitusannos on 0, 45 µg/ kg ihon alle tai laskimoon kertainjektiona kerran viikossa.